| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/12/2009 | CN101503397A Halogenated furan ketone compound, and use thereof in antiinfective drug preparation |
| 08/12/2009 | CN100526287C C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 08/12/2009 | CN100525761C Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572830 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572644 Polymerizable with acrylic monomers and acrylated polyethers; use of the hydrogel copolymer makes efficient removal of protein and high integration of nucleic acid and protein on a substrate for a microarray possible |
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/11/2009 | CA2174060C Inhibition of unsaturated monomers with 7-aryl quinone methides |
| 08/06/2009 | WO2009096409A1 Catalyst and reaction process |
| 08/06/2009 | WO2009094807A1 Compounds from mycelium of antrodia cinnamomea and use thereof |
| 08/06/2009 | WO2009057137A3 A process for the purification of levetiracetam |
| 08/06/2009 | US20090198071 Tetraphosphorus ligands for catalytic hydroformylation and related reactions |
| 08/06/2009 | US20090197925 O-cyclopropyl-carboxanilides and their use |
| 08/06/2009 | US20090197918 Pesticide benzyloxy- and phenetyl-substituted phenyl-amidine derivatives |
| 08/06/2009 | US20090196932 Pharmaceutical compositions of atorvastatin |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2084130A1 Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols |
| 08/05/2009 | EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101500994A 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 08/05/2009 | CN101500993A 2-aminocarbonylphenylamino-2-phenilacetamides as factor VIIa inhibitors useful as anticoagulants |
| 08/05/2009 | CN101497580A HIV-1 inhibitor 2-pyrrolidinone derivative, as well as synthesizing method and use thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569706 Chemically modifying a physiologically active polypeptide; improving the stability or water solubility |
| 08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
| 08/04/2009 | US7569599 Reacting alkylsulfonyl chloride in presence of base, cyanating, deblocking |
| 08/04/2009 | US7569598 Isomerization; crystallization |
| 08/04/2009 | US7569587 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | CA2560252C Process for the production of atorvastatin calcium in amorphous form |
| 07/30/2009 | WO2009094569A2 Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates |
| 07/30/2009 | WO2009094462A1 A crystalline synthetic intermediate for pyrrolidin-3-yl-glycylaminoalkylboronates |
| 07/30/2009 | WO2009094457A2 Substituted benzhydrylethers |
| 07/30/2009 | WO2009094260A1 Kappa selective opioid receptor antagonist |
| 07/30/2009 | WO2009093776A1 Method for the preparation of atorvastatin and intermediates used therein |
| 07/30/2009 | WO2009092642A1 Sulfonamides as orexin antagonists |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009073592A3 Sulfur containing fluoroalkyl amines and isocyanates |
| 07/30/2009 | WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation |
| 07/30/2009 | WO2008103613A3 Hydroxylamine compounds and methods of their use |
| 07/30/2009 | US20090192320 a polyalkylene glycol derivative having a reactive group, which can be combined with a bio-related substance, at the primary carbon at the 1-position of a glycerin skeleton and having polyalkylene glycol chains at the 2- and 3-positions |
| 07/30/2009 | US20090192191 Substituted hydroxamic acid derivatives as tnf inhibitors |
| 07/30/2009 | US20090192172 2-Alkyl-Cycloalk(en)yl-Carboxamides |
| 07/30/2009 | US20090192140 Iap bir domain binding compounds |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | CA2709050A1 Sulfonamides as orexin antagonists |
| 07/30/2009 | CA2706575A1 Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2081890A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 07/29/2009 | EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 07/29/2009 | EP1807407B1 Aromatic amides as inhibitors of c-fms kinase |
| 07/29/2009 | EP1756115A4 A new route to formyl-porphyrins |
| 07/29/2009 | EP1753748B1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | CN101495448A Alkoxyalkyl-substituted cyclic keto-enols |
| 07/29/2009 | CN101492406A Method for preparing amorphous atorvastatin calcium |
| 07/29/2009 | CN101492405A Method for preparing atorvastatin calcium |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/28/2009 | US7566803 Vitamin D receptor modulators |
| 07/28/2009 | US7566755 Compound and composition produced by using such compound |
| 07/28/2009 | US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics |
| 07/28/2009 | US7566683 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 07/28/2009 | CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/23/2009 | WO2009090544A2 Process for producing amorphous atorvastatin calcium |
| 07/23/2009 | WO2009090251A2 Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives |
| 07/23/2009 | WO2009090158A1 Atorvastatin-aliskiren |
| 07/23/2009 | WO2009089659A1 Pyrollidine-based compounds |
| 07/23/2009 | WO2009047568A3 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 07/23/2009 | WO2008087421A3 Male contraceptive |
| 07/23/2009 | US20090187030 Process for continuously preparing n-ethyl-2-pyrrolidone (nep) |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186873 3-Fluoro-4-[4-[2-(3,5-dimethylphenyl)pyrrolidin-1-yl-methyl]phenoxy]benzamide for treating alcoholism, ethanol use disorder withdrawal, and anxiety and/or depression, or schizophrenia |
| 07/23/2009 | US20090186834 Diphenylheterocycle cholesterol absorption inhibitors |
| 07/23/2009 | US20090186790 Photo-labile pro-fragrance conjugates |
| 07/23/2009 | CA2711529A1 Process and intermediates for the preparation of 5-bibphenyl-4-yl-2-methylpentanoic acid derivatives |
| 07/22/2009 | EP2080754A2 Organic compounds |
| 07/22/2009 | EP2079525A1 Calcium receptor modulating agents |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101489999A N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and usethereof as fungicides |
| 07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |
| 07/22/2009 | CN101486674A Preparation of glimepiride raw material |
| 07/22/2009 | CN101486673A Optical activity 2-(2-nitro-ethyl)-pyrrole, synthetic method and use |
| 07/22/2009 | CN101486672A Method for synthesizing trans-4-cyclohexyl-L-proline hydrochlorate |
| 07/22/2009 | CN100516041C Novel heteroaryl derivative |
| 07/22/2009 | CN100516040C Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 07/21/2009 | US7563912 new improved method for manufacturing chemical intermediate of (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidine acetamide which is used in therapy and prophylaxis epilepsy and other neurological disorders; stereospecific; industrial scale production, environmentally friendly |
| 07/21/2009 | US7563911 Process for the preparation of amorphous atorvastin calcium salt (2:1) |
| 07/21/2009 | US7563910 Heterocyclic cannabinoid receptor antagonists |
| 07/21/2009 | US7563909 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; fluvastatin 4-(nitrooxy)butyl ester |